<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<title>Advanced Biomed Inc. Announces 1 for 20 Share Consolidation</title>
<style>
body { font-family: Arial, Helvetica, sans-serif; background:#0f1115; color:#e6e6e6; margin:0; padding:40px; }
.container { max-width:700px; margin:auto; background:#161a21; border-radius:10px; padding:32px; box-shadow:0 0 30px rgba(0,0,0,0.4); }
h1 { margin-top:0; color:#4da3ff; }
table { width:100%; margin-top:12px; border-collapse:collapse; }
th, td { text-align:left; padding:6px 8px; border-bottom:1px solid #2a2f3a; }
ul { margin-top:12px; padding-left:20px; }
.section { margin-top:24px; }
.small { margin-top:12px; font-size:13px; color:#999; }
a { color:#4da3ff; }
</style>
</head>
<body>
  <div class="container">
    <h1>Advanced Biomed Inc. Announces 1 for 20 Share Consolidation</h1>

    <table>
      <tr><th>Ticker</th><td>ADVB</td></tr>
      <tr><th>Float</th><td>5.9 M</td></tr>
      <tr><th>IO</th><td>1.05%</td></tr>
      <tr><th>MC</th><td>5.2 M</td></tr>
      <tr><th>Extra Info</th><td>None</td></tr>
    </table>

    <div class="section">
      <strong>Summary</strong>
      <p>Advanced Biomed Inc. (NASDAQ: ADVB) announced a 1-for-20 reverse stock split effective at the open of Nasdaq on February 20, 2026. The reverse split was authorized by majority written consent on January 12, 2026 (per Nevada law) with the board selecting the final 1-for-20 ratio on January 30, 2026. The action is intended to regain compliance with Nasdaq Listing Rule 5550(a)(2) (minimum $1.00 bid price). After the consolidation the company’s issued and outstanding common shares will change from 27,290,710 to approximately 1,364,536; the authorized share count remains unchanged. Trading will continue under the existing ticker ADVB but with a new CUSIP (00752P203). No action is required by shareholders holding shares in brokerage accounts; no fractional shares will be issued and each stockholder will be entitled to receive one full share in lieu of any fractional share.</p>
    </div>

    <div class="section">
      <strong>Positives</strong>
      <ul><li>Reverse split intended to regain compliance with Nasdaq Listing Rule 5550(a)(2) (minimum $1.00 bid price)</li><li>Issued and outstanding shares will be reduced from 27,290,710 to approximately 1,364,536</li><li>Shares will continue trading under the same ticker (ADVB) with a new CUSIP (00752P203); no broker action required</li></ul>
    </div>

    <div class="section">
      <strong>Negatives</strong>
      <ul><li>None</li></ul>
    </div>

    <div class="section">
      <a href="https://news.nuntiobot.com/article/a4d2d432-36c0-4248-9b2c-6e7975477a22" target="_blank">Original Article</a>
    </div>

    <div class="small">ADVB • TradersLink AI News</div>
  </div>
</body>
</html>